229 related articles for article (PubMed ID: 28968738)
1. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in measles antibody titers in plasma donors and minimum antibody levels of immunoglobulin products for treatment of primary immunodeficiency.
Simon TL; FitzGerald P; Kühne M; Farrar C; Knowles J; Bycholski K; Zenker O
Transfusion; 2018 Dec; 58 Suppl 3():3065-3071. PubMed ID: 30536437
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
Wong-Chew RM; Beeler JA; Audet S; Santos JI
J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
[TBL] [Abstract][Full Text] [Related]
4. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
[TBL] [Abstract][Full Text] [Related]
5. Measles immunity and response to revaccination among secondary school children in Cumbria.
Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
[TBL] [Abstract][Full Text] [Related]
6. Measles antibody trough levels after treatment with immunoglobulin products and predicted levels assuming lower measles antibody specifications.
Vandeberg P; Cruz MC; Griffin R
Transfusion; 2018 Dec; 58 Suppl 3():3072-3077. PubMed ID: 30430616
[TBL] [Abstract][Full Text] [Related]
7. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
8. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
Dilraj A; Cutts FT; Bennett JV; Fernandez de Castro J; Cohen B; Coovadia HM
Pediatr Infect Dis J; 2000 Dec; 19(12):1211-3. PubMed ID: 11144388
[No Abstract] [Full Text] [Related]
9. Booster vaccination with further live attenuated measles vaccine.
Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
[TBL] [Abstract][Full Text] [Related]
10. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
[TBL] [Abstract][Full Text] [Related]
11. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels].
Sokhin AA; Sliusar' LI; Popov VF; Noskov FS; Radomskaia FS
Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):79-85. PubMed ID: 6637278
[TBL] [Abstract][Full Text] [Related]
12. Responses in children to measles vaccination associated with perirenal transplantation.
Mori K; Kawamura K; Honda M; Sasaki N
Pediatr Int; 2009 Oct; 51(5):617-20. PubMed ID: 19438829
[TBL] [Abstract][Full Text] [Related]
13. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
14. Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United States.
Farcet MR; Karbiener M; Rabel PO; Schirmer A; Ilk R; Kreil TR
Vaccine; 2019 May; 37(24):3151-3153. PubMed ID: 31060953
[TBL] [Abstract][Full Text] [Related]
15. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response.
Isa MB; Martínez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV
Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776
[TBL] [Abstract][Full Text] [Related]
16. Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.
Rainwater-Lovett K; Nkamba HC; Mubiana-Mbewe M; Bolton-Moore C; Moss WJ
J Infect Dis; 2013 Dec; 208(11):1747-55. PubMed ID: 23911708
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of maternal measles antibody titers and response to the measles vaccination at the age of 9 months in preterm infants.
Ozturk S; Kavuncuoglu S; Ozbek S; Vural M
Eur J Pediatr; 2007 Nov; 166(11):1181-2. PubMed ID: 17136351
[No Abstract] [Full Text] [Related]
18. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method].
Liashenko VA; Iuminova NV; Krasnova VP
Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428
[TBL] [Abstract][Full Text] [Related]
19. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
20. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
Liu BY; Feng ZX; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
